Cargando…
Can ceftriaxone be omitted in the treatment of nongonococcal pelvic inflammatory disease?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355632/ https://www.ncbi.nlm.nih.gov/pubmed/33910407 http://dx.doi.org/10.1177/09564624211004415 |
| _version_ | 1783736802365931520 |
|---|---|
| author | Ross, James Ian McConville Roads, Polly Morton D C Ross, Jonathan |
| author_facet | Ross, James Ian McConville Roads, Polly Morton D C Ross, Jonathan |
| author_sort | Ross, James Ian McConville |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8355632 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83556322021-08-13 Can ceftriaxone be omitted in the treatment of nongonococcal pelvic inflammatory disease? Ross, James Ian McConville Roads, Polly Morton D C Ross, Jonathan Int J STD AIDS Letter to the Editor SAGE Publications 2021-04-28 2021-09 /pmc/articles/PMC8355632/ /pubmed/33910407 http://dx.doi.org/10.1177/09564624211004415 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to the Editor Ross, James Ian McConville Roads, Polly Morton D C Ross, Jonathan Can ceftriaxone be omitted in the treatment of nongonococcal pelvic inflammatory disease? |
| title | Can ceftriaxone be omitted in the treatment of nongonococcal pelvic
inflammatory disease? |
| title_full | Can ceftriaxone be omitted in the treatment of nongonococcal pelvic
inflammatory disease? |
| title_fullStr | Can ceftriaxone be omitted in the treatment of nongonococcal pelvic
inflammatory disease? |
| title_full_unstemmed | Can ceftriaxone be omitted in the treatment of nongonococcal pelvic
inflammatory disease? |
| title_short | Can ceftriaxone be omitted in the treatment of nongonococcal pelvic
inflammatory disease? |
| title_sort | can ceftriaxone be omitted in the treatment of nongonococcal pelvic
inflammatory disease? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355632/ https://www.ncbi.nlm.nih.gov/pubmed/33910407 http://dx.doi.org/10.1177/09564624211004415 |
| work_keys_str_mv | AT rossjamesianmcconville canceftriaxonebeomittedinthetreatmentofnongonococcalpelvicinflammatorydisease AT roadspollymorton canceftriaxonebeomittedinthetreatmentofnongonococcalpelvicinflammatorydisease AT dcrossjonathan canceftriaxonebeomittedinthetreatmentofnongonococcalpelvicinflammatorydisease |